Company intelligence / Profile preview

Hunan Hui Bai Shi Biotechnology

Changsha, Hunan, China

Ownership: Private
Development stage: Other

Overview

Hunan Hui Bai Shi Biotechnology is not a pharmaceutical developer and so does not conduct clinical trials; it supplies reagents widely for research and commercial use globally, with quality meeting advanced standards domestically and internationally

Modalities: Small molecule (biochemical reagents including buffers, glycosides, protein reagents, antibiotics)
Industry: Chemicals & Materials

Partnerships

Collaborates extensively with research institutions and universities in China; details of specific institutional partners not specified

Beyond the preview

Go deeper on Hunan Hui Bai Shi Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hunan Hui Bai Shi Biotechnology.

Explore the full profile